Profluent says it has discovered AI ‘scaling laws’ for AI models used in protein design
XX min read
TL;DR
Oops! Something went wrong while submitting the form.
Share on Social
More media
December 9, 2025
Profluent Bio Announces Strategic Collaboration with Ensoma to Develop AI-Designed Base Editors for In Vivo Hematopoietic Stem Cell Therapies
Press
December 9, 2025
Profluent Bio Announces Strategic Collaboration with Ensoma to Develop AI-Designed Base Editors for In Vivo Hematopoietic Stem Cell Therapies
Press
